06/12/2025
8:01 AM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 424B5 | |
06/11/2025
6:41 AM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
3:23 PM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
8:49 AM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
4:26 PM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2025
7:00 AM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2025
4:12 PM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2025
3:35 PM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/11/2025
4:58 PM | Tempest Therapeutics, Inc. (Subject)
Tempest Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
02/06/2025
3:59 PM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 424B5 | |
01/27/2025
11:15 PM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form EFFECT | |
01/24/2025
3:35 PM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form S-3/A | |
12/31/2024
3:01 PM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
3:15 PM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
3:15 PM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form PRE 14A | |
10/10/2024
6:30 AM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 8-A12B/A | |
10/10/2024
6:16 AM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:03 AM | Tempest Therapeutics, Inc. (Subject)
Tempest Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
7:59 PM | Tempest Therapeutics, Inc. (Subject)
Tempest Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
08/12/2024
7:33 PM | Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Versant Side Fund IV, L.P. (Reporting)
Versant Vantage II GP, L.P. (Reporting)
Versant Vantage II GP-GP, LLC (Reporting)
Versant Vantage II, L.P. (Reporting)
Versant Venture Capital IV, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Ventures IV, LLC (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
2:41 PM | Tempest Therapeutics, Inc. (Subject)
Tempest Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
3:44 PM | Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
